Page 98 - AN-3-2
P. 98

Advanced Neurology                                          Genetics of neurodevelopmental disorders in Mexico



            Investigation:  Norma Elena de León-Ojeda, Adonis     hyperactivity disorder (ADHD). J Child Neurol. 2016;31:584-588.
            Estévez-Perera                                        doi: 10.1177/0883073815604223
            Methodology:  Norma Elena de León-Ojeda, Adonis
            Estévez-Perera                                     7.   Reilly C, Atkinson P, Memon A, et al. Autism, ADHD and
            Writing – original draft:  Norma Elena de León-Ojeda,   parent-reported behavioural difficulties in young children
                                                                  with epilepsy. Seizure. 2019;71:233-239.
            Alioth Guerrero-Aranda
            Writing – review & editing: Norma Elena de León-Ojeda,      doi: 10.1016/j.seizure.2019.08.003
            Alioth Guerrero-Aranda                             8.   Morris-Rosendahl DJ, Crocq MA. Neurodevelopmental
                                                                  disorders-the history and future of a diagnostic concept.
            Ethics approval and consent to participate            Dialogues Clin Neurosci. 2020;22(1):65-72.
            This study was approved by the Ethics Committee of the      doi: 10.31887/DCNS.2020.22.1/macrocq
            Hospital “Country 2000” (approval no.: CEHC-2023/014-02).  9.   Parenti I, Rabaneda LG, Schoen  H, Novarino G.

            Consent for publication                               Neurodevelopmental disorders: From genetics to functional
                                                                  pathways. Trends Neurosci. 2020;43(8):608-621.
            Complete written and  verbal  informed consent was      doi: 10.1016/j.tins.2020.05.004
            obtained from the adult subjects (relatives) and parents or
            legal guardians of the pediatric subjects for the publication   10.  Carlsson T, Molander F, Taylor MJ, Jonsson U, Bölte S.
                                                                  Early environmental risk factors for neurodevelopmental
            of this study.                                        disorders-a systematic review of twin and sibling studies.
            Availability of data                                  Dev Psychopathol. 2021;33(4):1448-1495.
                                                                  doi: 10.1017/S0954579420000620
            The datasets generated during and/or analyzed during the
            present study are available from the corresponding author   11.  Huang Y, Zhao Y, Ren Y, et al. Identifying genomic variations
            on reasonable request.                                in  monozygotic twins discordant for  autism  spectrum
                                                                  disorder using whole-genome sequencing. Mol Ther Nucleic
            References                                            Acids. 2019;14:204-211.

            1.   Gilissen  C, Hehir-Kwa  JY, Thung DT,  et al. Genome      doi: 10.1016/j.omtn.2018.11.015
               sequencing identifies major causes of severe intellectual   12.  Li Y, Jia X, Wu H, et al. Genotype and phenotype correlations
               disability. Nature. 2014;511(7509):344-347.        for SHANK3  de novo mutations in neurodevelopmental
               doi: 10.1038/nature13394                           disorders. Am J Med Genet A. 2018;176(12):2668-2676.
            2.   Baio J, Wiggins L, Christensen DL, et al. Prevalence of autism      doi: 10.1002/ajmg.a.40666
               spectrum disorder among children aged 8 Years-Autism and   13.  Rehder C, Bean LJ, Bick D, et al. Next-generation sequencing
               developmental disabilities monitoring network, 11 Sites,   for constitutional variants in the clinical laboratory, 2021
               United States, 2014. MMWR Surveill Summ. 2018;67(6):1-23.  revision: A  technical standard of the American college
               doi: 10.15585/mmwr.ss6706a1                        of medical genetics and genomics (ACMG).  Genet Med.
                                                                  2021;23(8):1399-1415.
            3.   Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde
               LA. ADHD prevalence estimates across three decades: An      doi: 10.1038/S41436-021-01139-4
               updated systematic review and meta-regression analysis. Int   14.  Buers I, Persico I, Schöning L, et al. Crisponi/cold-induced
               J Epidemiol. 2014;43(2):434-442.                   sweating syndrome: Differential diagnosis, pathogenesis
                                                                  and treatment concepts. Clin Genet. 2020;97(1):209-221.
               doi: 10.1093/ije/dyt261
            4.   Hermann B, Seidenberg M, Jones J. The neurobehavioural      doi: 10.1111/cge.13639
               comorbidities of epilepsy: Can a natural history be   15.  Margolis SS, Sell GL, Zbinden MA, Bird LM. Angelman
               developed? Lancet Neurol. 2008;7(2):151-160.       syndrome. Neurotherapeutics. 2015;12(3):641-650.
               doi: 10.1016/S1474-4422(08)70018-8                 doi: 10.1007/s13311-015-0361-y
            5.   Brunklaus  A,  Lal  D.  Sodium  channel  epilepsies  and   16.  Phelan MC, Stapleton GA, Rogers RC. Deletion 22q13
               neurodevelopmental disorders: From disease mechanisms to   syndrome:  Phelan-McDermid syndrome. In:  Management
               clinical application. Dev Med Child Neurol. 2020;62(7):784-792.  of Genetic Syndromes. 3  ed. United States: Wiley; 2010.
                                                                                   rd
               doi: 10.1111/dmcn.14519                            doi: 10.1002/9780470893159.ch21
            6.   Lee  EH,  Choi  YS,  Yoon  HS,  Bahn  GH.  Clinical  impact  of   17.  Kuht HJ, Thomas KA, Hisaund M, MacOnachie GD,
               epileptiform discharge in children with attention-deficit/  Thomas   MG. Ocular manifestations of PNPT1-related


            Volume 3 Issue 2 (2024)                         12                               doi: 10.36922/an.3359
   93   94   95   96   97   98   99   100   101   102   103